NanoString Skip Navigation

NanoString Technologies

1.888.358.6266

Site Navigation

  1. Applications Overview
    1. Applications Overview
    2. Technology
    3. Gene Expression Analysis
    4. miRNA Expression Analysis
    5. Copy Number Variation Analysis
    6. Publications
  2. Products Overview
    1. Products Overview
    2. nCounter Instrumentation
    3. nCounter Gene Expression
    4. nCounter miRNA Expression
    5. nCounter Custom CNV CodeSet
    6. nCounter Workflow
    7. Ordering Information
    8. Webinars and Videos
    9. Contact Sales
  3. Support Overview
    1. Support Overview
    2. FAQs
    3. Product Literature
    4. nCounter Software
    5. Contact Support
  4. Community Overview
    1. Community Overview
    2. Core & Service Lab Listings
    3. Upcoming Events
    4. Mail List
    5. Imagine
    6. Join nCounter Community
  5. Corporate Overview
    1. Corporate Overview
    2. Management Team
    3. Media Center
    4. Locations
    5. Contact Us
    6. Careers
    7. Legal

Site Tools


You are here:

  1. Home
  2. Corporate
  3. Executive Management Team
  4. H. Perry Fell, Ph.D.

Sectional Navigation

H. Perry Fell, Ph.D.

Dr. Fell served as CEO of NanoString Technologies from 2004 to 2009, and was previously Chairman of the Board. He also serves as a director of Impel NeuroPharma. Prior to NanoString, Dr. Fell co-founded and served as CEO of Seattle Genetics. Dr. Fell took Seattle Genetics public in 2001. Prior to his tenure at Seattle Genetics, Dr. Fell directed the Molecular Immunology Department at Bristol-Myers Squibb Pharmaceutical Research Institute. Dr. Fell holds an MBA from the University of Washington in Seattle, WA and a PhD in Immunology from Southwestern Medical School in Dallas, TX.

Image NanoString Technoloiges

Related Links